Cresskill, NJ, United States of America

Weijia Zhang

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Weijia Zhang**

Introduction

Weijia Zhang, based in Cresskill, NJ, is an accomplished inventor with a significant contribution to the field of medical science. With a total of six patents to his name, Zhang has made strides in improving patient outcomes in the realm of organ transplantation, particularly focusing on kidney allograft recipients.

Latest Patents

Zhang's most recent patents showcase his innovative approach to diagnosing and managing renal allograft health. His first notable patent is a **Method for Identifying Kidney Allograft Recipients at Risk for Chronic Injury**. This method allows for the identification of renal allograft recipients who may be at risk for chronic allograft damage by comparing the transcription levels of a preselected gene signature set with a set standard. If these levels are significantly elevated, it signifies a higher risk of chronic damage.

The second recent patent, titled **Method for Diagnosing Subclinical and Clinical Acute Rejection by Analysis of Predictive Gene Sets**, presents a novel approach for diagnosing acute cellular rejection of an allograft. This invention utilizes predictive gene sets and related kits for effective diagnosis of acute cellular rejection (ACR), further advancing the care of patients undergoing organ transplants.

Career Highlights

Weijia Zhang has had an impactful career, during which he collaborated with notable institutions. He has held positions at the **Icahn School of Medicine at Mount Sinai** and the **Western Sydney Local Health District**, where he contributed significantly to research and innovation in transplantation medicine. His work combines the latest advancements in genetics with clinical applications, showcasing his commitment to improving medical practices.

Collaborations

Throughout his career, Zhang has worked alongside prominent figures in the field, including Barbara Murphy and Philip J. J. O'Connell. These collaborations have fostered a multidisciplinary approach to tackling complex medical challenges and further propelled advancements in transplantation science.

Conclusion

Weijia Zhang's contributions through his patents and collaborations exemplify the spirit of innovation in the medical field. His focus on improving the diagnosis and management of kidney transplant-related issues highlights the critical role of inventive solutions in enhancing healthcare outcomes. As he continues to develop new methodologies, the impact of his work is sure to resonate within the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…